Evidence map›Paper›PMID 10839798›Full record

ReviewThe Journal of experimental medicine2000

Revising B cell receptors.

D Nemazee, M Weigert

Abstract readCommentReview
In one paragraph

Review in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. The enigmatic function of IgD: some answers at last.European journal of immunology · 2018
    Review
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

D NemazeeThe Scripps Research Institute, La Jolla, CA 92037, USA.
M Weigert

Funding

RECEPTOR EDITING IN B-CELLSR01AI033608 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1993 to 2010
$3.7M
B LYMPHOCYTE TOLERANCE IN HEALTH AND AUTOIMMUNITYR01GM044809 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1990 to 2009
$3.5M
NIAID NIH HHS R01 AI033608NIGMS NIH HHS R01 GM044809
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Rearrangement, B-LymphocyteAnimalsHumansImmunoglobulin Heavy ChainsImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin Variable RegionReceptors, Antigen, B-CellImmunoglobulin Heavy ChainsImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin Variable RegionReceptors, Antigen, B-Cell

Identifiers

PMID10839798
PMCPMC2213535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.